UNSPSC 51151674: Pinaverium bromide

Non-atropinic antispasmodic which is used for analgesia and correction of the altered gastrointestinal transit. It acts as calcium channel blocker over the muscle fiber of the digestive tract. It dicreases the acid quantity without either modifying the gastric secretion volume or accelerating the gastric evacuation.

UNSPSC 51151674 Pinaverium bromide is a Commodity code that nominally covers a specific gastrointestinal pharmaceutical product, but recent state and local solicitations tagged under this code do not align with pinaverium bromide procurement. Instead, the code appears to encompass pharmaceutical and health-system supply procurement more broadly. State and local health agencies—primarily county health departments and state health and human services commissions—are using this code to solicit diverse pharmaceutical products and pharmacy-related services, including opioid-reversal medications (naloxone), drug deactivation systems, and direct-to-manufacturer prescription program management. The issuing bodies consist primarily of county public-health agencies and state health departments. This divergence between the code's nominal scope and actual procurement activity suggests either a tagging inconsistency in state and local systems or a broader application of the commodity code to pharmaceutical procurement across multiple product lines.

Recent activity concentrates in Florida and Texas. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid response deadline was July 26, 2023, at 2:00 pm. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program, inviting responses from vendors experienced in direct pharmacy contracting for self-insured employers and state agencies. The Seminole County opportunity carries E-Verify and drug-free workplace requirements and includes a three-month probationary termination clause; no explicit set-asides are designated. The Texas RFI operates as exploratory market intelligence with no immediate award or formal evaluation criteria, designed to inform future RFP development.